ADMARE
LIVE

Serial Number

88711511

Owner

adMare BioInnovations

Attorney

Michael Pampalone

Filing Date

Dec 2, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ADMARE Trademark

Serial Number: 88711511

ADMARE is a trademark filed by adMare BioInnovations on December 2, 2019. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

adMare BioInnovations (11 trademarks)

Vancouver, BC V6T1Z3 , CA

Entity Type: 03

Trademark Details

Filing Date

December 2, 2019

Registration Date

Not Registered

Goods & Services

providing consulting services in the commercialization of products and services in the field of pharmaceuticals, namely, consulting services in intellectual property, commercial transactions, corporate structuring, and pharmaceutical regulatory affairs; providing consulting services for life sciences incubator and accelerator services in the commercialization of products and services in the field of pharmaceuticals, namely, consulting services in intellectual property, commercial transactions and corporate structuring

providing educational programs and training services in the field of pharmaceutical research, development, commercialization, leadership and management, namely, conducting classes, courses, seminars, webinars, workshops, conferences, networking events, mentorship programs, and executive coaching; providing educational programs and training services in the field of pharmaceutical research, development, commercialization, leadership and management, namely, conducting classes, courses, seminars, webinars, workshops, conferences, networking events, mentorship programs and executive coaching, all for undergraduate students, post-graduate trainees and life sciences researchers, scientists, and professionals; providing educational programs and training services in leadership and management for senior or executive-level life sciences researchers, scientists, and professionals, namely, conducting classes, courses, seminars, webinars, workshops, conferences, executive coaching, networking events, and mentorship programs; providing educational programs and training services in the field of pharmaceutical research, development and commercialization for post-graduate trainees, namely, conducting classes, courses, seminars, webinars, workshops, conferences, networking events and mentorship programs; providing educational programs and training services in the field of pharmaceutical research, development and commercialization for undergraduate students, namely, conducting classes, courses, seminars, webinars, workshops, conferences, networking events, and mentorship programs

providing scientific and medical research information and drug discovery information in the field of pharmaceuticals; providing scientific consulting services in the field of pharmaceutical research and development; providing research, inspection, evaluation, testing and development services in the field of pharmaceutical research, and development; providing laboratory research services relating to pharmaceutical research and development; providing technical support services, namely, troubleshooting in the nature of diagnosing problems with computerized or electronic laboratory equipment and instruments; organizing and conducting meetings, gatherings, conferences and networking events in the field of pharmaceutical research and development; providing scientific and technical advice for life sciences incubator and accelerator services, namely, scientific and technical advice in the field of laboratory equipment and instruments, technical support services, namely, troubleshooting in the nature of diagnosing problems with computerized or electronic laboratory equipment and instruments, and information technology consulting services; providing scientific and medical laboratory services for life sciences incubator and accelerator services; providing laboratory and office facilities in the field of pharmaceutical research and development, namely, office workspace, office furniture, office equipment, information technology equipment, scientific research laboratories, laboratory equipment and instruments, meeting rooms, conference rooms, and laboratory reagents; providing laboratory and office facilities for life sciences incubator and accelerator services, namely, office workspace, office furniture, office equipment, information technology equipment, scientific research laboratories, laboratory equipment and instruments, meeting rooms, conference rooms and laboratory reagents

providing job and research personnel placements for business internship, post-doctoral research and undergraduate research; providing scientific consulting services in the field of pharmaceutical commercialization; providing business consulting services in the commercialization of products and services in the field of pharmaceuticals, namely, consulting services in sourcing investments and partners, and analyzing and advancing projects; providing business consulting services for life sciences incubator and accelerator services, namely, consulting services in the commercialization of products and services in the field of pharmaceuticals, consulting services in sourcing investments and partners, and analyzing and advancing projects; providing office facilities in the field of pharmaceutical commercialization, namely, office workspace, office furniture, office equipment, information technology equipment, meeting rooms, and conference rooms; providing office facilities for life sciences incubator and accelerator services, namely, office workspace, office furniture, office equipment, information technology equipment meeting rooms, and conference rooms

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 18, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 24, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 23, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 22, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 22, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 21, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 4, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 4, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jan 4, 2024 CNSL
ASSIGNED TO EXAMINER
Jan 4, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 21, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 14, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 14, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 14, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 5, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 28, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 28, 2023 GNSL
SUSPENSION LETTER WRITTEN
Feb 28, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2023 CRFA
ASSIGNED TO LIE
Feb 23, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 13, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 15, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 15, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 15, 2022 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 17, 2022 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 4, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 4, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 4, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 4, 2022 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 24, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 24, 2022 GNSL
SUSPENSION LETTER WRITTEN
Mar 24, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 7, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 13, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 13, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 13, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 16, 2021 RCCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 5, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 5, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 5, 2021 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 5, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 5, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 5, 2021 COAR
ASSIGNED TO EXAMINER
May 19, 2021 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 18, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 18, 2020 GNSL
SUSPENSION LETTER WRITTEN
Nov 18, 2020 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 18, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 18, 2020 GNSL
SUSPENSION LETTER WRITTEN
Nov 18, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2020 CRFA
ASSIGNED TO LIE
Oct 19, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 4, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 4, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 7, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2019 NWOS
NEW APPLICATION ENTERED
Dec 5, 2019 NWAP